Technology Development
Business Development
Revenue
Exited
About
VisageX’s adjustable implant technology enables post-operative adjustments through non-invasive structural volume expansion. This distinctive feature allows the implant to adapt to the patient’s evolving aesthetic needs over time, representing a groundbreaking platform in plastic and reconstructive surgery. Our technology delivers personalized aesthetic outcomes by offering structural control, minimal invasiveness, with a hollow volume self tissue growth scaffold.
Clinical Milestone – Successfully conducted First-in-Human (FIH) implantation with encouraging clinical results, validating value proposition in humans.
Market Need
The global market for facial plastic and reconstructive implants (combined) is projected to reach $5B by 2032, with a compound annual growth rate (CAGR) of 8%. VisageX holds a substantial competitive advantage, as there are currently no direct competitors offering a comparable product solution.
